Dr. V\u00f6r\u00f6s Imre: Neuropeptides in cardioprotection and cardiovascular diseases (2024) T\u00e9mavezet\u0151: Dr. Varga Zolt\u00e1n \u00e9s Dr. S\u00e1ghy \u00c9va<\/p>\n
Dr. Kucsera D\u00e1niel: Targeting IL-1\u03b2 and assessing sex specific molecular differences in mouse models of Nonalcoholic steatohepatitis (2023) T\u00e9mavezet\u0151: Dr. Varga Zolt\u00e1n<\/p>\n
Dr. G\u00e1sp\u00e1r Attila:Cognitive characterization of Long-Evans rats in a streptozotocin-induced Alzheimer\u2019s disease model (2023) T\u00e9mavezet\u0151: Dr. Gyerty\u00e1n Istv\u00e1n<\/p>\n
Dr. Makkos Andr\u00e1s: Novel cardioprotective mechanism in translational models of the ischemic heart (2023) T\u00e9mavezet\u0151: Dr. G\u00f6rbe Anik\u00f3, Prof. Dr. Ferdinandy P\u00e9ter<\/p>\n
Dr. Szepesy Judit: Szenzorineur\u00e1lis hall\u00e1sk\u00e1rosod\u00e1sok \u00e9s lehets\u00e9ges gy\u00f3gyszeres ter\u00e1pi\u00e1juk – az immunrendszer lehets\u00e9ges szerepe (2022) T\u00e9mavezet\u0151: Dr. Zelles Tibor, Dr. Szirmai \u00c1gnes<\/p>\n
Dr. Hanuska Adrienn: Az NMDA receptorok modul\u00e1ci\u00f3j\u00e1nak vizsg\u00e1lata a percepci\u00f3 \u00e9s a kognit\u00edv funkci\u00f3k zavaraiban (2022) T\u00e9mavezet\u0151: Dr. K\u00f6les L\u00e1szl\u00f3<\/p>\n
Dr. Guly\u00e1s-On\u00f3di Zs\u00f3fia: Immune-inflammatory targets in chronic heart failure: inflammasomes and the endocannabinoid system (2022) T\u00e9mavezet\u0151: Dr. Varga Zolt\u00e1n<\/p>\n
Dr. Mohammadzadeh Amir: Glycine transporter inhibitors in management of neuropathic pain (2022) T\u00e9mavezet\u0151: Dr. Mahmoud Al-Khrasani<\/p>\n
Dr. Brenner G\u00e1bor: Novel aspects of cardiac ischemia\/reperfusuion injury in translational drug development (2021) T\u00e9mavezet\u0151: Dr Giricz Zolt\u00e1n<\/p>\n
Dr. \u00c1gg Bence K\u00e1roly: Unbiased, network theoretic approaches to identify novel therapeutic targets in cardiovascular comorbidities\u00a0(2020) T\u00e9mavezet\u0151: Prof. Dr. Ferdinandy P\u00e9ter<\/p>\n
Dr. Berekm\u00e9ri Eszter: A Corti-f\u00e9le szerv t\u00e1maszt\u00f3sejtjeinek vizsg\u00e1lata fejl\u0151d\u00e9sben l\u00e9v\u0151 \u00e9s kifejlett hall\u00e1s\u00fa egerek hemicochlea prepar\u00e1tum\u00e1ban\u00a0(2020) T\u00e9mavezet\u0151: Dr. Zelles Tibor<\/p>\n
Nagy Csilla: Investigation of novel therapeutic options for the treatment of ischemic and metabolic cardiovascular diseases (2020) T\u00e9mavezet\u0151: Dr. Giricz Zolt\u00e1n<\/p>\n
Dr. Balogh Mih\u00e1ly: Peripheral and central analgesic components of a novel opioid in the management of inflammatory and neuropathic pain (2019) T\u00e9mavezet\u0151: Dr. Al-Khrasani Mahmoud<\/p>\n
Dr. T\u00f3th Vikt\u00f3ria \u00c9va: \u00daj mechanizmusok a gyomor ny\u00e1lkah\u00e1rtya v\u00e9delemben: az endocannabinoid rendszer szerep\u00e9nek vizsg\u00e1lata (2019) T\u00e9mavezet\u0151k: Dr. Gyires Kl\u00e1ra, Dr. Z\u00e1dori Zolt\u00e1n<\/p>\n
Koncsos G\u00e1bor: A metabolikus elv\u00e1ltoz\u00e1sok kardiovaszkul\u00e1ris rendszerre kifejtett k\u00f6vetkezm\u00e9nyei: a mitokondri\u00e1lis oxidat\u00edv stressz \u00e9s autof\u00e1gia szerepe (2019) T\u00e9mavezet\u0151: Dr. Giricz Zolt\u00e1n<\/p>\n
Dr. Feh\u00e9r \u00c1gnes: Az imidazolin receptorok gasztrointesztin\u00e1lis hat\u00e1sainak farmakol\u00f3giai anal\u00edzise (2018) T\u00e9mavezet\u0151: Dr. Z\u00e1dori Zolt\u00e1n<\/p>\n
Dr. Baranyai Tam\u00e1s: Remote ischemic conditioning and its molecular mechanism in the heart (2017) T\u00e9mavezet\u0151: Dr. Ferdinandy P\u00e9ter<\/p>\n
Horv\u00e1th Tam\u00e1s: Parakrin szab\u00e1lyoz\u00e1s\u00fa v\u00e9dekez\u0151 mechanizmusok vizsg\u00e1lata a Corti szervben (2016) T\u00e9mavezet\u0151: Dr. Zelles Tibor<\/p>\n
Nashwan Shujaa: Analysis of the role of cannabinoid receptors and a2-adrenoceptor subtypes in gastrointestinal functions (2011)
\nT\u00e9mavezet\u0151: Dr. Gyires Kl\u00e1ra<\/p>\n
Kir\u00e1ly Korn\u00e9l: A dipeptidil peptid\u00e1z IV enzim \u00e9s inhibitorainak szerepe az endomorphin 2 bioszint\u00e9zis\u00e9ben (2011)
\nT\u00e9mavezet\u0151: Dr. R\u00f3nai Andr\u00e1s<\/p>\n
Kat\u00f3 Erzs\u00e9bet: Interaction of peptidergic, biogenic amine and amino acid transmitters in the integration of central and peripheral autonomic functions. Pharmacological characterization of some opioid derivatives and of \u03b12B adrenoceptor (2011).
\nT\u00e9mavezet\u0151: Dr. R\u00f3nai Andr\u00e1s<\/p>\n
Szebeni Andrea: Az 1-es t\u00edpus\u00fa diabetes mellitus patomechanizmus\u00e1nak immunog\u00e9n h\u00e1ttere \u00e9s kardiovaszkul\u00e1ris sz\u00f6v\u0151dm\u00e9nyei (2010)
\nT\u00e9mavezet\u0151: Dr.Kecskem\u00e9ti Val\u00e9ria<\/p>\n
Z\u00e1dori Zolt\u00e1n: A gyomorny\u00e1lkah\u00e1rtya integrit\u00e1s\u00e1t \u00e9s a gasztrointesztin\u00e1lis motilit\u00e1st szab\u00e1lyoz\u00f3 mechanizmusok anal\u00edzise (2009)
\nT\u00e9mavezet\u0151: Dr. Gyires Kl\u00e1ra<\/p>\n
Balogh Brigitta: Az MDMA hat\u00e1sai a vigilanci\u00e1ra \u00e9s neuronk\u00e1ros\u00edt\u00f3 hat\u00e1s\u00e1nak farmakol\u00f3giai k\u00f6vetkezm\u00e9nyei (2008)
\nDr. Bagdy Gy\u00f6rgy<\/p>\n
Gonda X\u00e9nia: A szerotonin transzporter g\u00e9n \u00e9s a szem\u00e9lyis\u00e9g: az 5-HTTLPR s all\u00e9l, a szorong\u00e1s, a depresszi\u00f3 \u00e9s az affekt\u00edv temperamentumok \u00f6sszef\u00fcgg\u00e9se (2008)
\nT\u00e9mavezet\u0151: Dr. Bagdy Gy\u00f6rgy<\/p>\n
F\u00fcl\u00f6p Katalin: A gyomorny\u00e1lkah\u00e1rtya integrit\u00e1sa \u00e9s a gyomormotilit\u00e1s. Az \u03b12 adrenoceptor szubt\u00edpusok gyomormotilit\u00e1s szab\u00e1lyoz\u00e1s\u00e1ban j\u00e1tszott szerep\u00e9nek farmakol\u00f3giai anal\u00edzise patk\u00e1nyon (2008)
\nT\u00e9mavezet\u0151: Dr. Gyires Kl\u00e1ra<\/p>\n","protected":false},"excerpt":{"rendered":"
Dr. V\u00f6r\u00f6s Imre: Neuropeptides in cardioprotection and cardiovascular diseases (2024) T\u00e9mavezet\u0151: Dr. Varga Zolt\u00e1n \u00e9s Dr. S\u00e1ghy \u00c9va Dr. Kucsera D\u00e1niel: Targeting IL-1\u03b2 and assessing sex specific molecular differences in mouse models of Nonalcoholic steatohepatitis (2023) T\u00e9mavezet\u0151: Dr. Varga Zolt\u00e1n Dr. G\u00e1sp\u00e1r Attila:Cognitive characterization of Long-Evans rats in a streptozotocin-induced Alzheimer\u2019s disease model (2023) T\u00e9mavezet\u0151: …<\/p>\n","protected":false},"author":110,"featured_media":0,"parent":81,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-472","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/users\/110"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/comments?post=472"}],"version-history":[{"count":12,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/472\/revisions"}],"predecessor-version":[{"id":13274,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/472\/revisions\/13274"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/pages\/81"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/media?parent=472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/categories?post=472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/pharmacology\/wp-json\/wp\/v2\/tags?post=472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}